Skip to main content
NUS logo

NUS

Nu Skin Enterprises, Inc.
$5.08 -0.09 (-1.74%) At close · Jul 8
Market Cap
$246.64M
Shares
48,550,543

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$1.49B -14.3%
FY2025 Revenue FY2011–FY2025
Net Income
$160.2M +209.3%
FY2025 Net Income FY2010–FY2025
Gross Margin
69.45% +1.2pp
FY2025 Gross Margin FY2011–FY2025
Operating Margin
4.43% +13.2pp
FY2025 Operating Margin FY2011–FY2025
Diluted EPS
$3.18 +207.8%
FY2025 Diluted EPS FY2010–FY2025
Operating Cash Flow
$80.29M -28.2%
FY2025 Operating Cash Flow FY2010–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
$1.44B $1.49B $1.73B $1.97B $2.23B $2.7B $2.58B $2.42B $2.68B $2.28B $2.21B $3.18B $2.17B $1.74B
$442.38M $453.76M $550.23M $611.85M $630.92M $675.22M $658.03M $581.42M $634.14M $502.08M $500.46M $489.51M $478.43M $505.81M $353.15M $322.62M $272.43M
$998.9M $1.03B $1.18B $1.36B $1.59B $2.02B $1.92B $1.84B $2.04B $1.78B $1.71B $1.76B $2.09B $2.67B $1.82B $1.42B $1.26B
69.45% 68.23% 68.93% 71.65% 74.95% 74.51% 75.98% 76.33% 77.97% 77.33% 84.08% 83.72% 81.5%
$10.8M $13M $22.6M $23.3M $27.2M $23.3M $30.1M $23M $22M $24.3M $20.1M $18.9M $18M $14.9M $13.6M
$417.48M $432.14M $479.04M $546.86M $555.77M $666.4M $646.85M $615.97M $662.3M $564.51M $554.15M $561.46M $622.3M $640.03M $505.45M $436.18M $401.42M
$7.1M $12.3M $11.9M $9.7M $11.7M $9.8M $13.4M $18.3M $8.1M $8.4M $8.6M $8.4M $7.8M
$50.4M $52.26M $69.81M $70.92M $72.51M $76.32M $73.99M $76.65M $83M $71.56M $72.4M $71.37M $54.92M $34.92M $33.41M $32.85M $29.62M
$88.4M $22.1M $22.1M $22.1M $0 $0
$919.21M $965.64M $1.33B $1.31B $1.48B $1.79B $1.67B $1.57B $1.8B $1.5B $1.48B $1.51B $1.74B $2.12B $1.48B $1.19B $1.05B
$79.69M $65.76M -$151.59M $48.27M $110.85M $233.99M $257.56M $267.43M $240.86M $274.48M $231.1M $244.7M $352.19M $554.11M $340.84M $233.74M $217.06M
4.43% -8.75% 2.45% 4.98% 8.68% 9.98% 11.05% 8.99% 12.04% 10.47% 17.44% 15.71% 13.4%
$130.09M $118.02M -$81.78M $119.19M $183.35M $310.31M $331.56M $344.08M $323.86M $346.05M $303.5M $316.07M $407.11M $589.04M $374.26M $266.59M $246.68M
$14.92M $13.95M $26.41M $25.6M $13.5M $11M $13.1M $19.2M $21.8M $22.2M $15.6M $7.9M $5.7M $3M $5.2M $4.8M
-$582K -$31.78M $2.94M -$21.69M -$21.88M -$1.53M -$1.33M -$12.25M -$21.19M -$8.92M -$18.27M -$32.74M -$53.68M $2.83M $4.4M -$6.97M -$9.45M
$0 $0 $456K $1.05M
$64.2M $196.2M -$175.05M $26.58M $88.97M $232.46M $256.23M $255.17M $219.67M $265.57M $212.84M $211.96M $298.51M $556.94M $345.24M $226.77M $207.61M
$9.67M $35.99M -$28.46M $17.98M -$15.81M $85.19M $64.88M $81.62M $97.78M $136.13M $69.75M $78.91M $109.33M $192.05M $123.6M $73.44M $71.56M
$54.53M $160.2M -$146.59M $8.6M $104.78M $147.27M $191.36M $173.55M $121.89M $129.44M $143.09M $133.05M $189.18M $364.89M $221.65M $153.33M $136.05M
10.79% -8.46% 0.44% 4.71% 5.46% 7.41% 7.17% 4.55% 5.68% 6.48% 11.49% 10.22% 8.79%
$60M $168.86M -$171.35M -$4.9M $92.17M $138.14M $211.88M $168.2M $108.27M $147.24M $130.23M $113.3M $183.88M $370.48M $232.39M $145.65M
USD/shares $3.25 -$2.95 $0.17 $2.10 $2.93 $3.66 $3.13 $2.21 $2.45 $2.58 $2.29 $3.20 $6.23 $3.66 $2.47 $2.18
USD/shares $0.70 – $1.10 $3.18 -$2.95 $0.17 $2.07 $2.86 $3.63 $3.10 $2.16 $2.36 $2.55 $2.25 $3.11 $5.94 $3.52 $2.38 $2.11
shares 49.29M 49.66M 49.71M 50M 50.19M 52.3M 55.52M 55.17M 52.81M 55.41M 58M 59.07M 58.61M 60.6M 62.07M 62.37M
shares 50.3M 49.66M 49.86M 50.53M 51.43M 52.77M 55.93M 56.48M 54.85M 56.1M 59.06M 60.89M 61.45M 63.03M 64.55M 64.55M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2010–FY2025: $1.39B in buybacks, $999.6M in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
EV/EBIT
P/E (TTM)
4.70×
Household & Personal Products median 22.45×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Americas Segment $282,975,000 $322,516,000 $398,222,000 $508,537,000 $547,755,000 $453,022,000 $304,422,000
Southeast Asia Pacific Segment $209,802,000 $244,846,000 $267,206,000 $344,411,000 $336,651,000 $361,627,000 $346,276,000
Manufacturing Segment $205,788,000 $201,430,000 $181,395,000 $149,458,000 $172,120,000 $149,339,000 $121,917,000 $90,606,000
Mainland China Segment $195,553,000 $235,235,000 $298,079,000 $360,389,000 $568,774,000 $625,538,000 $722,526,000 $886,472,000
Japan Segment $174,364,000 $181,557,000 $207,833,000 $224,896,000 $266,216,000 $273,681,000 $260,039,000 $254,939,000
Europe And Africa Segment $150,151,000 $164,164,000 $192,352,000 $204,275,000 $283,200,000
South Korea Segment $130,216,000 $163,706,000 $236,099,000 $268,707,000 $354,252,000 $326,478,000 $329,978,000 $373,357,000
Hong Kong Taiwan Segment $117,378,000 $130,610,000 $153,589,000 $157,197,000 $162,611,000 $161,117,000 $166,335,000 $185,893,000
Rhyz Other Segment $17,794,000 $85,188,000 $35,214,000 $3,830,000 $437,000 $0 $0
Americas Pacific Segment $511,941,000 $349,078,000 $385,034,000
Emea Segment $283,200,000 $230,246,000 $167,165,000 $182,394,000
Grow Tech Segment $2,104,000 $903,000 $137,000 $0
Nu Skin $2,523,112,000
Nu Skin Segment $2,523,112,000 $2,432,595,000 $2,298,362,000 $2,588,402,000
Rhyz Investments Segment $172,557,000 $149,339,000 $122,054,000
Rhyz $172,557,000
Southeast Asia Segment $302,708,000 $301,620,000 $316,890,000
Corporate $3,653,000 $886,000 $1,621,000 $3,423,000

By Product & Service (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Wellness $689,062,000 $757,217,000 $886,093,000 $992,338,000 $1,062,549,000 $922,553,000 $863,125,000 $921,328,000
Beauty $568,113,000 $681,765,000 $858,625,000 $1,069,714,000 $1,442,659,000 $1,491,803,000 $1,423,485,000
Other Product Lines $227,984,000 $293,102,000 $224,413,000 $163,607,000 $190,461,000 $167,578,000 $133,806,000 $97,943,000
Devices And Related Consumables $618,000,000
Personal Care $1,423,485,000 $1,659,737,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Americas Segment $60,488,000 $67,717,000 $78,943,000 $97,298,000 $103,067,000 $86,386,000 $52,135,000
Japan Segment $48,972,000 $50,798,000 $54,076,000 $51,620,000 $65,167,000 $68,027,000 $61,081,000 $56,676,000
Southeast Asia Pacific Segment $46,775,000 $45,230,000 $47,743,000 $75,902,000 $72,774,000 $87,753,000 $90,666,000
Mainland China Segment $45,555,000 $46,090,000 $62,259,000 $72,362,000 $151,645,000 $181,024,000 $191,570,000 $253,598,000
South Korea Segment $37,459,000 $50,746,000 $74,091,000 $78,811,000 $110,328,000 $100,933,000 $99,892,000 $107,215,000
Hong Kong Taiwan Segment $37,172,000 $34,689,000 $40,582,000 $32,584,000 $34,065,000 $33,466,000 $33,569,000 $33,392,000
Europe And Africa Segment $22,633,000 $21,009,000 $18,592,000 $15,959,000 $34,846,000
Manufacturing Segment $7,813,000 $1,460,000 $12,321,000 $3,570,000 $18,346,000 $21,168,000 $15,693,000 $7,754,000
Rhyz Other Segment -$30,593,000 -$45,809,000 -$20,564,000 -$6,180,000 -$1,813,000 $0 $0
Americas Pacific Segment $91,627,000 $57,090,000 $52,433,000
Emea Segment $21,446,000 $41,988,000 $24,078,000 $10,195,000 $14,773,000
Grow Tech Segment -$83,907,000 -$22,430,000 -$19,509,000 -$9,228,000
Nu Skin $376,286,000 $424,536,000 $571,892,000
Nu Skin Segment $462,190,000 $610,552,000 $581,667,000 $539,108,000 $596,685,000
Rhyz Investments Segment -$2,610,000 $16,533,000 $21,168,000 -$3,816,000
Rhyz -$8,243,000 -$2,610,000 $16,533,000
Southeast Asia Segment $75,538,000 $82,455,000 $78,598,000

Operating Margin by Segment (%)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Americas Segment 21.4% 21% 19.8% 19.1% 18.8% 19.1% 17.1%
Southeast Asia Pacific Segment 22.3% 18.5% 17.9% 22% 21.6% 24.3% 26.2%
Manufacturing Segment 3.8% 0.7% 6.8% 2.4% 10.7% 14.2% 12.9% 8.6%
Mainland China Segment 23.3% 19.6% 20.9% 20.1% 26.7% 28.9% 26.5% 28.6%
Japan Segment 28.1% 28% 26% 23% 24.5% 24.9% 23.5% 22.2%
Europe And Africa Segment 15.1% 12.8% 9.7% 7.8% 12.3%
South Korea Segment 28.8% 31% 31.4% 29.3% 31.1% 30.9% 30.3% 28.7%
Hong Kong Taiwan Segment 31.7% 26.6% 26.4% 20.7% 20.9% 20.8% 20.2% 18%
Rhyz Other Segment -171.9% -53.8% -58.4% -161.4% -414.9%
Americas Pacific Segment 17.9% 16.4% 13.6%
Emea Segment 14.8% 10.5% 6.1% 8.1%
Grow Tech Segment -3988% -2483.9% -14240.1%
Nu Skin 22.7%
Nu Skin Segment 24.2% 23.9% 23.5% 23.1%
Rhyz Investments Segment 9.6% 14.2% -3.1%
Rhyz 9.6%
Southeast Asia Segment 25% 27.3% 24.8%
Key facts CIK 1021561 CUSIP 67018T105 13F (30d) 5 filings 4 filers Visit website Investor relations